ORIGINAL RESEARCH article
Front. Vet. Sci.
Sec. Veterinary Infectious Diseases
Volume 12 - 2025 | doi: 10.3389/fvets.2025.1614479
Quantitative Evaluation of the Efficacy of Non-replicating Vaccines for Controlling African Swine Fever in Domestic Pigs: A Systematic Review and Meta-Analysis
Provisionally accepted
- Jeonbuk National University, Jeonju, Republic of Korea
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: The African swine fever virus (ASFV), prevalent globally, causes high mortality and morbidity in domestic pigs. However, there is a lack of effective treatment or vaccines against ASFV infection despite the ongoing research in this field. Methods: In this systematic review and meta-analysis, we conducted a quantitative evaluation of the efficacy of non-replicating vaccines against ASFV. The vaccine efficacy (VE) was analyzed based on three key disease outcomes: mortality, fever, and clinical symptoms after infection. Results: The search of relevant electronic databases yielded 23 studies for inclusion in the review. Vaccination with subunit vaccines significantly reduced mortality risk in vaccinated pigs compared to that in controls (p = 0.02), with a relative risk (RR) of 0.90 (95% CI: 0.83–0.98), indicating a VE of 10% (95% CI: 2–17). However, subunit vaccines did not substantially reduce the risk of fever and other clinical symptoms in vaccinated pigs, with a RR of 0.97 (95% CI: 0.93–1.01) for both outcomes. Moreover, inactivated vaccines did not provide any protection against mortality (RR = 1.01, 95% CI: 0.95–1.06) or other clinical signs (RR = 1.00, 95% CI: 1.00–1.00). No significant between-study heterogeneity was detected, indicating consistent findings across different vaccination trials. Thus, currently available non-replicating vaccines fail to deliver the protection required for field applications. Conclusions: Currently, subunit vaccines are more likely to serve as long-term options for vaccine development strategies. Further research is essential to deepen our understanding of the roles and significance of humoral and cellular immune responses against ASFV, and to identify critical viral antigens that can induce effective protective immunity.
Keywords: African Swine Fever Virus, Inactivated, subunit, vaccine efficacy, Meta-analysis
Received: 18 Apr 2025; Accepted: 22 Aug 2025.
Copyright: © 2025 Ntakiyisumba, Tanveer, Hirwa and Won. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Gayeon Won, Jeonbuk National University, Jeonju, Republic of Korea
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.